Partner of Choice
Building strong collaborative relationships is fundamental to the development of any drug or healthcare company. Our aim is to couple the Syntopix scientific and research capabilities with the late stage development and marketing expertise of our chosen partners.
We aim to be your partner of choice by offering:
- leading specialists in topical drug discovery with world class antimicrobial expertise;
- exceptional understanding of screening for beneficial antimicrobial compound combinations;
- proven methodologies for identifying and repositioning known compounds for novel antimicrobial applications;
- the scientific and commercial capability to assist in brand or product differentiation; and
- scientific integrity and professionalism to ensure strong and lasting alliances.
Recent News
23/08/2010 07:00
AGREEMENT WITH GLOBAL CONSUMER PRODUCTS COMPANY
Syntopix signs an exclusive agreement with a world leading health and personal care brands company.
22/06/2010 07:00
Syntopix welcomes a new board member with Mike Townend joining as Non-executive Director
22/04/2009 13:13
03/02/2010 07:00
Syntopix announces a Directorate change with Tom Bannatyne joining as Chairman.
12/11/2009 07:00
Syntopix announces positive results for its lead dermatological compound SYN0126
